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Pregnant rabbit liver membranes have been shown 
to possess two types of receptors by displacement anal- 
ysis, a growth hormone (GH) receptor which binds 
bovine growth hormone with an affinity constant (&) 
of 3 X 10’ M-’ and ovine prolactin with a KA of 3 x 10’ 
M-‘, and a prolactin (Prl)-specific receptor which binds 
ovine prolactin with a & of 5 X 10’ M-‘. The prolactin- 
specific receptor when solubilized with Triton exhibits 
a 4-fold increase in its KA while the KA of the growth 
hormone receptor decreases slightly to 2 x 10’ M-’ after 
solubilization. The lo-fold difference in affinity which 
results has been exploited to facilitate the separation 
of these two receptors by differential affinity chroma- 
tography on human growth hormone (hGH) affinity 
gels. The growth hormone receptor is eluted from the 
gel with 4 M urea while 5 M MgClz is required to elute 
the prolactin receptor. Conditions of affinity chroma- 
tography have been optimized, and further purification 
of the GH receptor by preparative isoelectric focusing 
and Sepharose 6B gel filtration resulted in a more than 
8000-fold purification of the receptor. This material had 
a Stokes radius of 62 A, consistent with a molecular 
weight of 300,000 and gave one main band (75,000 to 
80,000) and two minor bands on sodium dodecyl sulfate 
(SDS) polyacrylamide gels, which could be interpreted 
as indicating a tetrameric receptor. The GH receptor 
was shown to be a sialoglycoprotein (or closely asso- 
ciated with sialoglycoprotein) by analytical isoelectric 
focusing with an isoelectric point of 4.6. Specificity 
studies with the highly purified receptor confirmed the 
initial hypothesis that this receptor is capable of bind- 
ing bovine growth hormone (bGH) with high affinity 
and ovine prolactin (oPr1) with low affinity, in contrast 
to the prolactin-specific receptor. 
Among the receptors for classical hormones, the growth 
hormone receptor has remained the least well characterized, 
partly because of the problem of defining a biologically signif- 
icant end point for GH’ action in vitro and partly because 
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many of the anabolic actions of GH are mediated by the 
somatomedins. Nevertheless, a number of workers (l-4) have 
demonstrated that binding to the presumptive GH receptor is 
a saturable and reversible process with structural specificity 
and high affinity, dependent on time, temperature, pH, and 
ionic environment in a manner similar to the other poly- 
peptide hormone receptors (reviewed by Refs. 5-7). 
While Lesniak et al. (3, 8,9) have made significant contri- 
butions with their studies of GH receptors in cultured human 
lymphocytes, most workers have tended to study the liver GH 
receptor. This is largely because the liver content of GH 
receptor has been found to be greater than any of the other 
tissues in the species so far examined, the rabbit (2), the rat 
(2, 10, II), the mouse (12), the sheep (13), and man (14). The 
three classical sites of GH action in the rat (diaphragm, 
adipose tissue, and skeletal muscle (l&16)) show little binding 
activity (17), but this does not mean that functional GH 
receptors are absent. 
The liver has been extensively studied as a target organ for 
GH in the rat, in large part because of its role as the major 
producer of somatomedin, the peptide effector of many of the 
effects of GH on cartilage and skeletal muscle (18, 19). In 
addition to this role, GH increases protein and RNA synthesis 
(RNA polymerase) in the liver (20) and activity of a number 
of enzymes such as ornithine decarboxylase, tyrosine amino 
transferase, and tryptophan pyrrolase (21). Growth hormone 
also has metabolic effects on the liver; thus gluconeogenesis 
in the liver is decreased by GH treatment of hypophysecto- 
mized rata (22) and so is esterification of fatty acids (15). 
Sonenberg’s group have studied the effects of GH on liver cell 
membranes rather extensively and have found small but re- 
producible differences in the spectral characteristics of the 
membranes indicative of a conformational change, as well as 
an increase in Mg*+ATPase activity in the presence of GH 
(23). 
The pregnant rabbit liver is the richest known source of GH 
receptors (17) and for this reason has been the subject of 
several attempts to purify the receptor. Herington and Veith 
(24) characterized the binding of lz51-hGH to Triton X-lOO- 
solubilized membranes and found the binding parameters to 
be essentially identical with those of the membranes. Mc- 
Intosh et al. (25) and Gottsman and Werder (26) have both 
reported small-scale purifications of a “hGH receptor” from 
rabbit liver, but neither group has attempted to separate the 
GH receptor from the prolactin receptors which are known to 
be present in rabbit liver (2, 27). McGuffln et al. (28) have 
presented one other study with soluble human GH receptors 
produced by iodoacetamide treatment of IM9 lymphocytes. 
Apparent oversight of the fact that human GH possesses both 
lactogenic and somatotropic actions in nonprimate species 
(29) and hence binds to lactogenic as well as growth hormone 
receptors (2) has made interpretation of the above studies on 
nonprimate “growth hormone” receptors difficult. 
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6816 Purification of a Nonprimate Growth Hormone Receptor 
MATERIALS AND METHODS 
Hormones used for binding analysis (bovine growth hormone, NIH 
bGH 1003A; ovine growth hormone, NIH oGH 098; human growth 
hormone. NIH hGH HS1652C: ovine nrolactin. NIH oPr1 S12. NIH 
rat prolactin RP2; bovine prolactin, NIH bPr1 PlB3) were gifts of the 
National Institutes of Health. Human prolactin (hPrl-95% pure by 
radioimmunoassay) was prepared by the method of Hwang et al. (30), 
and the hGH used for coupling to affinity supports (1 IU/mg) was 
prepared by the method of Raben (31). NIH bGH B18 was also 
coupled in some experiments. Rabbit antisera to oGH and bPr1 were 
raised in our laboratory using standard techniques. Antisera to the 
rabbit mammary prolactin receptor were prepared by the method 
described by Shiu and Friesen (32). Lactoperoxidase (B grade) was 
obtained from Calbiochem and Na[““I] from either New England 
Nuclear or Amersham/Searle. Neuraminidase (type VI) and P-galac- 
tosidase were purchased from Sigma. Triton X-100 was supplied by 
Rohm and Haas Co. and Triton X-305 by Sigma. Bovine y-globulins 
(Fraction II) were from Calbiochem and bovine serum albumin from 
Sigma or ICN. The N-hydroxysuccinimide ester of 3,3’-diaminodipro- 
pylaminosuccinyl agarose (Affi-Gel 10) was obtained from Bio-Rad 
Laboratories. Phenylmethanesulfonyl fluoride was purchased from 
Sigma and Trasylol from Boehringer Mannheim. Urea was Schwarz- 
Mann ultrapure material, and guanidine hydrochloride was purchased 
from Eastman Organic Chemicals. Ampholytes were supplied by LKB 
Instruments, Inc., and Sepharose 6B or Sephadex G-100 (medium) by 
Pharmacia. SDS gel reagents were from Bio-Rad Laboratories and 
molecular weight markers from Schwarz/Mann. Ultrafiltration was 
performed on Amicon ultrafdtration cells, models 12 and 400, with 
Amicon UM2 membranes. 
Receptor Preparation-Membranes for binding studies were pre- 
pared from late pregnant or early suckling rabbit mammary gland 
and liver by the methods described by Shiu and Friesen (33) and 
Tsushima and Friesen (l), respectively. Rabbits were purchased from 
Fauna Breeding Farms, Quebec. In some cases mammary glands 
purchased from Pel-Freez Biologicals were used. If solubilization of 
receptor was desired, these glands could not be stored frozen for 
prolonged periods, since solubilization efficiency was found to decline 
after several weeks at -20°C. Solubilization was effected by adding 
Triton X-100 or Triton X-305 (final concentration 1% v/v) to the 
resuspended membrane pellet and stirring for 10 min at room tem- 
perature. Before adding Triton, membranes were resuspended in an 
equivalent volume of the original tissue weight with 25 mM Tris-HCl 
buffer, pH 7.4, to give a final protein concentration of 5 to 10 mg/ml. 
This suspension was then centrifuged at 200,006 x g for 90 min and 
the clear infranatants removed by suction. Extracts were used within 
16 h (at 4’C) or stored frozen at -2OOC to avoid precipitation. 
lo&nations-The hGH, bGH, oGH, and oPr1 used as tracers were 
iodinated by the method of Thorell and Johansson (34) as modified 
by Shiu et al. (35). Routinely, 5 pg of hormone was reacted with 1 
mCi of Na[““I] and two 3 nM additions of Hz02 for 10 min at pH 7.0 
and 22OC, in a final volume of 85 ~1. In the case of oGH and bGH, 
iodinations were carried out at pH 4.3 for a total of 20 min. Fraction- 
ation of the iodination mixture was carried out on Sephadex G-106 
columns after addition of 0.9 ml of Tris-HCl buffer, pH 7.4, and 
appropriate fractions were stored for up to 3 weeks, at -20°C. Specific 
activities ranged from 75 to 120 pCi/pg for hGH and oPr1, and 20 to 
40 pCi/pg for oGH and bGH. 
Binding Assays-(i) Membrane binding assays were carried out by 
the methods described by Shiu and Friesen (33) for rabbit mammary 
prolactin receptors, except that incubation times were 15 to 18 h at 
22°C (shaking at 30 cycles/min) for oPr1 and hGH binding to prolactin 
receptors, and 3 h at 22°C or overnight at 4°C for oGH, bGH, and 
hGH binding to growth hormone receptors. These conditions have 
been shown to be optimal for binding both by us and by other workers 
(1). Reactions were stopped by the addition of 6 volumes of chilled 
assay buffer, and separation of bound from free tracer was performed 
by centrifugation (1600 x g) at 4°C for 20 min. 
(ii) Binding assays for solubilized receptors were performed accord- 
ing to the method of Cuatrecasas (36) and involved polyethylene 
glycol (PEG) 6000 precipitation of hormone. receptor complexes, fol- 
lowed by centrifugation as described above. Incubation times were 
identical with those used for membrane-binding assays. Solutions 
were always diluted to give less than 0.05% Triton in the assay tube. 
Herington and Veith (24) have reported the use of this method with 
solubilized rabbit liver extracts in detail. 
Protein Assays-Membrane concentrations were estimated by the 
method of Lowry et al. (37). Soluble receptor protein estimations 
were carried out by a variety of methods. The routine Lowry method 
was used for all crude solubilized extracts, except that the yellow 
precipitate which forms in the presence of Triton X-100 was removed 
by centrifugation, and standards were made up in sample buffer (25 
rnM Tris-HCl, 0.1% Triton X-100, pH 7.4). Ji (38) has shown that both 
Tris and Triton X-100 inhibit color development to some extent in 
the Lowry method. The modified Lowry method of Bensadoun and 
Weinstein (39) (involving precipitation with trichloroacetic acid in 
the presence of deoxycholate) was used for samples containing Am- 
pholine or for samples containing less than 10 pg/ml. The Coomassie 
blue staining method of McKnight (40) was also used on affinity- 
purified fractions prior to isoelectric focusing. 
Preparation of hGH and bGH Affinity Gels-hGH and bGH were 
coupled at pH 8.5 to the N-hydroxysuccinimide ester of 3,3’-diami- 
nodipropylaminosuccinyl agarose (Affi-Gel IO) according to the in- 
structions of the manufacturer (Bio-Rad). Percentage of coupling was 
monitored by the addition of ‘““I-hGH or ?-bGH to the coupling 
mixture, and after extensive washing of the coupling gel, determina- 
tion of the amount of radioactivity bound to 50-mg lots of gel. 
Coupling was stopped (after an overnight 4°C incubation) by the 
addition of 5 ml of 1 M ethanolamine-HCl, pH 8.5, per 10 g of wet gel, 
and a further incubation for 2 h at 22°C. Washing of the gel was 
accomplished on a Buchner funnel by the sequence (for 30 ml of gel): 
2 liters of 0.1 M NaHC03, 500 ml of 8 M urea in 0.1 M NaHC03, 1 liter 
of 0.1 M NaHC03, 300 ml of 5 M guanidine HCl in 0.1 M NaHC03, 1 
liter of 0.1 M NaHC03, 1 liter of 2 M NaCl, 0.05 M sodium acetate/ 
acetic acid, pH 4.0, 1 liter of 0.1 M NaHC03, 1 liter of 0.2 M NaHzPO+ 
2 liters of 0.025 M Tris-HCl, 0.1% Triton X-100, pH 7.4 (Tris/Triton), 
500 ml of 5 M MgC12 in Tris/Triton, 1 liter of Tris/Triton. The gel 
was finally incubated with 2 volumes/volume of soluble rabbit liver 
membrane extract in the presence of the protease inhibitors 0.3 m&r 
phenylmethanesulfonyl fluoride and 5000 Kallikrein inactivating units 
of Trasylol for 2 h at 22°C to release “labile” bound hormone, and 
the gel washed again with 6 M urea followed by 5 M MgC12 in Tris/ 
Triton and finally 2 liters of Tris/Triton alone. Release of “labile” 
bound hormone (monitored as “‘1 counts, but detectable by radiore- 
ceptor assay) can be reduced 80% by the addition of these protease 
inhibitors. However, precycling of the gel is still necessary to avoid a 
high level (micrograms per ml of extract) of released hormone in 
soluble extracts when these extracts are being recycled during puri- 
fication. Carryover of released hormone into purified receptor frac- 
tions is also decreased by this maneuver. 
Conditions of Affinity Chromatography-The development of op- 
timum conditions for affinity chromatography will be described under 
“Results.” Generally, the gel was washed extensively with Tris-Triton 
buffer just prior to addition of Triton-solubilized extract (5 volumes 
of extract/l volume of gel), then shaken gently for 2 h at 22°C in the 
presence of 10 mM MgCL and 0.3 lll~ PhCHzSOzF with 5000 Kalli- 
krein inactivating units of Trasylol/lOO ml of extract. Triton extracts 
of rabbit liver have a tendency to become turbid on storage at 4°C so 
that these extracts were either used very soon after preparation or 
stored frozen. When necessary, clarification of turbid extracts was 
achieved by centrifugation for 20 min at 15,000 x g prior to incubation 
with the affinity gel. 
After incubation, the gel was poured into a column (1.7 x 15 cm) 
with sintered glass support and washed under gentle suction with at 
least 150 volumes of ice-cold Tris/Triton buffer. The gel was then 
eluted slowly with 3 volumes of 4 M urea in Tris/Triton and the urea 
eluate collected in ice. The column was subsequently washed with 5 
volumes of 6 M urea in Tris/Triton, followed by Tris/Triton, and then 
eluted slowly with 3 volumes of 5 M MgC12 in Tris/Triton (at 3O’C) 
into ice. After another extensive wash with Tris/Triton, the gel was 
ready for recycling of the extract. Urea and MgClz eluates were 
dialyzed twice against 50 volumes of Tris/Triton at 4”C, and assayed 
for binding prior to concentration on Amicon UM2 ultrafiltration 
membranes or by dialysis against Ficoll. Great care must be taken 
with ultrafiltration to avoid loss of receptors onto the UM membranes 
when volumes become small. 
Preparative Column Isoelectric Focusing (IEF)-Further puriii- 
cation of the affinity-purified GH receptor fraction was achieved by 
use of an LKB column isoelectric focusing unit (110 ml, model 8100) 
according to the manufacturer’s instructions. The pH gradient was 
constructed by mixing 1.4 ml of pH 5 to 7 Ampholine and 1.4 ml pH 
2.5 to 4 Ampholine into the sample, along with sucrose as directed, in 
order to maximize the load. Focusing was normally carried out for 48 
h at 4”C, in 0.1% Triton X-190. Fractions were collected and adjusted 
to pH 7.5 with 2 M HCl or 2 M NaOH before assaying for binding 
activity. Recovery of 75 to 85% of applied binding activity was usually 
achieved. 
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Purification of a Nonprimate Growth Hormone Receptor 
Preparative Sepharose 6B Gel Filtration-After concentration on 
Amicon ultrafilters, the pooled post-IEF fractions were dialyzed 
against 1 M NaCl in Tris/Triton and approximately 20-ml lots applied 
to a column (118 X 2.55 cm) of Sepharose 6B equilibrated with Tris/ 
Triton buffer. The column was run at 4°C with a 60.cm head and a 
flow rate of 17 ml/h, and 8-ml fractions were collected. This column 
was calibrated with various molecular weight markers, including blue 
dextran and Na[“?], and was used for the determination of the 
approximate molecular weight of the purified receptor. Normally 70 
to 80% of the applied binding activity was recovered. 
Sodium Dodecyl Sulfate (SDS)-This was performed by the 
method of Laemmli (41) using a Bio-Rad vertical slab gel unit with 
0.75-mm thick gels. When necessary, samples were concentrated on 
Minicon A 25 cells prior to boiling for 2 min in mercaptoethanol 
buffer, and SDS gels were stained with 0.2% Coomassie blue in 50% 
trichloroacetic acid, then destained as usual in methanol/acetic acid/ 
water. In some cases the Triton could not be reduced to a sufficiently 
low level by Bio-Bead SM2 treatment or by dialysis prior to concen- 
tration, because both of these treatments resulted in loss of receptor 
protein. In these cases the Triton formed a mixed micelle with the 
SDS and migrated at the front during electrophoresis. 
Analytical Isoelectric Focusing-Horizontal slab gel isoelectric 
focusing was carried out on an LKB Multiphore unit, using riboflavin- 
polymerized 3.5% acrylamide, 0.1% methylene bisacrylamide gels con- 
taining 0.1% Triton X-100. A pH 3.5 to 9.0 gradient was used, and 
samples were applied to Whatman No. 1‘ M wicks on the cathodal 
side, in the region corresponding to a fin .u pH of about 7.0. Uniformity 
of the pH gradient and sieving effects were monitored by the appli- 
cation of ferritin (a rust colored protein of molecular weight 450,000 
with similar isoelectric point (~1) to the receptor) to the wicks on the 
right and left extremes of the slab. Gels were focused for 4 h at 4°C 
and 8 watts, and at the end of the run 0.5~cm slices were taken from 
each channel and eluted overnight at 4°C in 1.0 ml of 0.1 M Tris/ 
Triton buffer, pH 7.5. The pH gradient was evaluated by eluting the 
extreme right and left channels with water, followed by direct deter- 
mination of pH. Samples were assayed for binding activity by first 
adjusting all fractions to pH 7.5 with 2 M NaOH or HCl, and then 
assaying specific binding in 150~~1 aliquots with PEG. Coomassie blue 
staining of control gels showed numerous finely focused bands dis- 
tributed throughout the gradient. Recoveries of binding activity 
ranged from 60 to 120% of that applied, and Ampholine did not inhibit 
the binding at up to 0.1% w/v. 
RESULTS 
Growth Hormone and Prolactin Receptor Content of 
Rabbit Liver 
Initial studies of the GH and prolactin receptor contents of 
rabbit liver membranes led to the rather surprising conclusion 
that oPr1 at high concentrations is capable of fully displacing 
lz51-bGH from its receptor and that bGH is capable of dis- 
placing about half of the ‘251-oPrl bound to these membranes 
(Fig. 1). Radioimmunoassay (RIA) for oGH contamination of 
NIH S12 oPr1 gave <O.l%, yet the displacement curve analysis 
suggested an equivalent of at least 5% contamination with 
oGH. Similarly, radioimmunoassay estimation of the bPr1 
content of NIH BHG 1003A gave a figure of 0.02%, well below 
the figure of over 16% obtained from the displacement curves. 
Furthermore, the displacement by bGH appeared to plateau 
at around 50% of oPr1 specific binding. This also implies that 
the apparent site sharing was not due to cross-contamination. 
A study of the ability of other prolactins to displace ‘251-oGH 
from rabbit liver (Fig. 2) showed that the effect was not 
restricted to ovine prolactin; bovine prolactin (sequence nearly 
identical with oPr1, (42)) and to a lesser extent, human pro- 
lactin (<0.25% hGH by radioimmunoassay) were also effec- 
tive. 
Scatchard (43) analysis of the two pairs of curves obtained 
with ‘251-oPrl and lz51-bGH indicated heterogeneity of ‘251-oPrl 
binding only when oPr1 was used as the displacing ligand, but 
a single class of sites when bGH was used (Fig. 3). Displace- 
ment of lz51-bGH with either bGH or oPr1 indicated a single 
class of sites, although the latter were of low affinity. These 
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FIG. 1. A, displacement curves; “‘1-bGH binding to rabbit liver 
membranes, displacement by NIH bGH 1003A or NIH oPr1 512. 
Rabbit liver membrane protein (230 pg) was incubated with 73,000 
cpm of ?-bGH in assay buffer (25 mu Tris HCl, 10 mM MgC12,0.1% 
bovine serum albumin, pH 7.4) with varying concentrations of bGH 
or oPr1 in a final volume of 0.5 ml, shaking at 30 cycles/mm. Incuba- 
tions were for 3 hr at 22”C, and the assay was stopped by the addition 
of 3 ml of ice cold assay buffer followed by centrifugation for 20 min 
at 1600 x g at 4°C. Tubes were drained and counted, and the graph 
shows total bound counts plotted against displacing hormone concen- 
tration, expressed as a percentage of the precount. Duplicates are 
shown as two symbols at each concentration. No corrections were 
made for percentage of bindable hormone. The radioimmunoassay 
estimate of oGH contamination of oPr1 was obtained from a standard 
double antibody assay using NIH oGH 098 standards and our own 
specific antiserum. A, bGH 1003A; n , oPr1 S12. B, displacement 
curves; “‘I-oPr1 binding to rabbit liver membranes, displacement by 
NIH bGH 1003A or NIH oPr1 S12. Rabbit liver membranes (230 pg) 
were incubated with 78,060 cpm of “‘I-oPr1 for 16 h at 22°C using the 
assay procedure described in A. The radioimmunoassay estimate of 
bPr1 contamination of the bGH was obtained by the standard double 
antibody method using NIH P-38 bPr1 standards and our own specific 
antiserum. A, bGH 1003A; 0, oPr1 S12. 
data can be interpreted as showing two types of receptor in 
rabbit liver, a shared “growth hormone” receptor with high 
affinity (Ka 3 X 10’ M-l) for bGH and a low affinity (& 3 x 
10’ M-‘) for oPr1, and a “prolactin” receptor with high affinity 
for oPr1 only (KA 5 X 10’ M-l). The low affinity ‘251-oPrl 
binding to the “growth hormone” receptor site would thus be 
displaced very effectively by bGH (high &), but poorly by 
oPr1 (low affinity site in the ‘251-oPrl-oPrl curve). Clearly these 
figures for affinity are only approximations in view of the 
complexity of the situation, particularly with respect to lz51- 
oPr1 binding. 
We have confirmed the observation of Shiu and Friesen 
(33) that ‘251-oPrl hinding to rabbit mammary membranes, on 
the other hand, is not inhibited by bGH, even up to 10 pg/ml 
of standard NIH bGH 1003A. Thus the mammary gland 
possesses a highly specific prolactin receptor, and this would 
appear to be very similar to the analogous receptor in the 
liver, since anti-mammary Prl receptor antisera also inhibited 
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6818 Purification of a Nonprimate Growth Hormone Receptor 
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FIG. 2. Displacement curves; ability of various prolactins to dis- 
place ‘*‘I-oGH from rabbit liver membranes. Rabbit liver membrane 
protein (156 pg) was incubated with 74,000 cpm of ‘251-oGH for 3 hr 
at 22°C in the presence of various prolactin standards or bGH, as 
shown. Assay method is given in Fig. 1. 10 pg/ml of oPr1, bPr1, and 
human Prl standards gave total displacement of specific ““I-oPrl 
binding to rabbit mammary membranes, while the rat prolactin gave 
86% displacement at 10 pg/ml. 0, hPr1 (95%); A, bGH 1003A; Cl, bPr1 
P-B3; A, rat prolactin RP2; W, oPr1 S12. 
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FIG. 3. Scatchard analysis of bGH and oPr1 binding to rabbit liver 
membranes. Curves shown were derived from the data of Fig. 1. 
Upper left, ?-bGH displaced by bGH; upper right, ‘*“I-bGH dis- 
placed by oPrl; lower left, ““I-oPrl displaced by bGH; and lower right, 
‘*“I-oPr1 displaced by oPr1. The binding capacities Qo for growth 
hormone displacement, Q,, for prolactin displacement (high affinity 
species) are derived from these data using 230 pg of membrane 
protein. The values calculated for each affinity constant (&) repre- 
sent the mean of four separate membrane preparations (values f 
SD.). 
in large part ‘2”I-oPrl binding to liver membranes although 
lz51-bGH binding was not affected (Ref. 32, confirmed by us). 
Chromatography 
Clearly any preparative method for growth hormone recep- 
tors must separate this apparently shared “growth hormone” 
receptor from the prolactin-specific receptor. The use of anti- 
prolactin receptor columns, while superficially attractive, was 
precluded by the problem of generating sufficient antibody for 
large scale procedures. We have investigated a number of 
other methods including isoelectric focusing (which was not 
successful owing to the heterogeneity of charge on these 
receptors) and preincubation of liver extracts with high con- 
centrations of oPr1 to block prolactin receptors before affinity 
chromatography on hGH-affinity columns. The latter method 
was partially successful, but a rather more successful method 
was based on the difference in affinities of the two receptors 
after solubilization of the membranes with Triton X-100. 
One of the unusual characteristics of the rabbit mammary 
prolactin receptor is the &fold increase in affinity for ‘251-hGH 
which results from solubilization of the receptor with Triton 
X-100 (44). We have found a similar phenomenon with the 
rabbit liver prolactin receptor; on solubilization the affinity of 
o: 1.0 2.0 3.0 4.0 5.0 6.0 
MOLARITY OF UREA WASH 
0’ 
I 
1.0 2.0 3.0 4.0 5.0 6.0 
MOLARITY OF UREA 
FIG. 4. A, hGH affinity chromatography; effect of concentration of 
urea wash on subsequent recovery of hGH receptor in MgC12 eluate. 
3.5-g lots of affinity gel hGH (coupled 15 mg of hGH/g of wet gel, 3.5- 
g lots) were incubated with 12 ml of Triton X-IOO-solubilized rabbit 
mammary or rabbit liver extracts (see under “Materials and Methods” 
for solubilization) for 6 h at 22°C (shaking) for the mammary extract 
or 4 h at 22°C (shaking) for the liver extract. The 25 mM Tris-HCl, 
0.1% Triton X-100, pH 7.4, buffer contained 0.3 mu PhCHSOxF and 
5000 Kallikrein inactivating units of Trasylol, plus 10 mM MgClx. At 
the end of the incubation, gels were poured into glass columns (1.7 
x 15 cm) and after a 150-volume wash with chilled Tris-Triton, 
washed with 3 volumes of varying concentrations of freshly prepared 
urea in Tris/Triton buffer at 22°C. After the urea wash, columns were 
eluted with 3 volumes of 5 M MgClx and the eluates dialyzed exten- 
sively against Tris/Triton at 4°C. These MgCL eluates were then 
assayed for ?-hGH specific binding with PEG. Percentage of recov- 
ery was calculated relative to the control (0 M urea) yield which was 
20.2% for the mammary extract and 9% for the liver extract (based on 
specific binding). 0, mammary extract; 0, liver extract. B, hGH 
affinity chromatography; yield of bGH binding in urea wash as a 
function of urea concentration. Conditions identical with A except 
that only liver extract was used, and the columns were eluted with 3 
volumes of urea wash before the MgC12. The urea was dialyzed and 
assayed for ‘*“I-bGH binding. 
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Purification of a Nonprimate Growth Hormone Receptor 
the receptors for prolactin (I’?-0Pr1, high affinity site) in- 
creases 4-fold, from 5 X lo9 Me’ to 2 X 10” M-‘. The binding 
of growth hormone (lz51-bGH-bGH) on the other hand shows 
little change on solubilization (& 3 X lo9 Mm’ for membranes 
compared to 2 X lo9 M-’ for solubilized membranes). Thus 
solubilization of these two receptors leads to a lo-fold differ- 
ence in affinity for the common ligand (29,45) hGH. 
6819 
unlabeled hormone, 3 times as much trace was displaced by 
bGH than by oPr1. Thus the preliminary conclusion was 
reached that the urea fraction represented the “shared” GH 
receptor. Further support for this conclusion was provided by 
a study with bGH-affinity columns. In this case the yield of 
‘251-oPrl binding material in the 5 M MgCL fraction was very 
low, and since the column had not been washed with 6 M urea 
after the 4 M urea treatment was probably accountable to 
carryover of the shared GH receptor. 1251-bGH binding in the 
urea fraction was again displaceable by bGH and oPr1 with a 
ratio of 3:l at 1000 rig/ml. 
In order to examine the hypothesis that prolactin and GH 
receptors could be separated by differential affinity chroma- 
tography on hGH affinity columns, we incubated Triton X- 
lOO-solubilized rabbit liver and mammary extracts with hGH- 
coupled Affi-Gel columns under identical conditions and after 
a buffer wash, washed the columns with various concentra- 
tions of urea before eluting the lactogen receptors with 5 M 
MgClz (44). It can be seen from Fig. 4A that the urea wash 
has no effect on the receptor yield with the prolactin-specific 
receptor from the mammary gland, but with the liver only 
about half of the binding activity was recovered. Accordingly, 
the experiment was repeated with the liver extract, but this 
time the urea wash was assayed for ‘251-bGH binding. Fig. 4B 
shows that growth hormone binding was obtained in the urea 
wash with maximal yield at 4 M urea. This is very similar to 
the concentration reported by Cuatrecasas (46) to be effective 
in eluting the insulin receptor from its affinity columns. It 
would seem that 6 M urea partly inactivates the receptor, as 
it does the insulin receptor (46). 
In an effort to determine if a separation of receptors had 
been achieved, we examined displacement of both ‘251-oPrl 
and 1251-bGH by bGH and oPr1 in the urea and MgC12 frac- 
tions. As a further control bGH affinity columns were used 
for comparison; these gave a considerably lower yield but 
were presumed to be specific for only the growth hormone 
receptor. These studies showed that, after washing the hGH 
affinity column with 6 M urea, the subsequent 5 M MgC12 
eluate did not bind ‘251-bGH and that bGH was almost totally 
ineffective in displacing ‘251-oPrl from this fraction (Fig. 5), 
suggesting that this fraction contained, predominantly, lacto- 
genie hormone receptor. ‘251-oPrl binding to the urea fraction, 
on the other hand, was displaced to a similar extent by both 
bGH and oPr1. The ‘251-bGH binding characteristics of this 
fraction were such that in the presence of 1000 rig/ml of 
INITIAL CONCENTRATION OF STANDARD {ng/ml.j 
FIG. 5. Displacement curve analysis showing separation of GH and 
prolactin receptors by differential affinity chromatography on hGH 
affinity columns. Left side, lZ51-bGH tracer; right side, ?-oPr1 tracer. 
Top row, crude T&on X-100 extract; middle row, 4 M urea eluate; 
lower row, 5 M MgCL eluate. Displacement by A, NIH bGH 1003A or 
0, NIH oPr1 S12. Dialyzed extracts prepared according to Fig. 4 were 
diluted with assay buffer to give the specific binding (% S.B.) values 
shown. 
In summary, the specificity studies gave strong support to 
the notion that 4 M urea treatment of hGH affinity columns 
provides a means of separating GH receptors from prolactin- 
specific receptors in Triton extracts of rabbit liver membranes. 
Optimization of Yields from Affinity Chromatography 
Working on the assumption that these two fractions repre- 
sented the growth hormone and prolactin receptors of rabbit 
liver, we proceeded to optimize the conditions of affinity 
chromatography for GH receptors, with the hope of improving 
on the low yields. 
Firstly, in accord with the law of mass action, a high 
concentration of coupled hormone and soluble receptor was 
found to be essential for good yields. Thus, increasing the 
concentration of a fixed total amount of receptor in the Triton 
extract from 38 to 192 to 384 fmol/ml increased the yield from 
2.2 to 5.8 to 8.0%, respectively. Similarly, the yield of GH 
receptor was found to be 6, 9, and 12% when 4, 8, and 16 mg 
of hGH were coupled per g of gel (triplicate experiments). The 
desirability of using gels with high concentrations of coupled 
ligand has led us to include the protease inhibitors 
PhCH2S02F and Trasylol in the incubation mixture. These 
substances inhibit the release of coupled ‘251-hGH from the 
gel by about 80%, and their action leads to sustained yields of 
receptor at higher coupled hormone concentrations, since 
leakage off the columns and formation of soluble hGH-recep- 
tor complexes is greatly reduced, as is presumably, degrada- 
tion of the receptor. This point is important with batchwise 
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FIG. 6. Yield of growth hormone and prolactin binding activity 
from hGH affinity gels incubated with liver extracts for varying 
periods of time. hGH affinity gel was incubated with liver extract 
(2.75 g of gel/E ml of extract) as described in Fig. 4, and at various 
times the gels were poured into columns, washed with cold buffer, 
and eluted with 4 M urea, 6 M urea, and then 5 M MgCl,. Eluates (4 
M urea and 5 M MgCL) were dialyzed and assayed for ‘*‘I-bGH and 
‘251-oPrl binding after dialysis. Percentage of specific binding per 100 
~1 of dialysate (corrected for volume differences) is shown for lz51- 
bGH-bGH (urea) (0) and ‘251-oPrl-oPrl (MgC12) (0). Points are the 
average of two experiments. 
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6820 Purification of a Nonprimate Growth Hormone Receptor 
treatment, and we have found (especially in the case of the 
prolactin receptor) that batchwise treatment gives a some- 
what better yield than the column method under these con- 
ditions. The reason for this is apparent from a consideration 
of Figs. 6 and 7. Fig. 6 shows the yield of receptor as a function 
of incubation time, and it can be seen that while 2 h is 
sufficient for GH receptor purification, a rather prolonged 
incubation (11 h) is required for prolactin receptor purifica- 
tion. Fig. 7 shows the time course of ‘251-hGH binding in 
soluble liver extracts, with displacement by oPr1 or bGH, 
assayed by PEG separation. The same order of difference in 
binding rates is apparent, although a strict comparison of the 
two is not possible owing to the differences in hormone con- 
centration and mobility. 
An examination of the optimal pH of incubation during 
affinity chromatography again showed a difference between 
GH and prolactin receptors. In this case, the yield was seen to 
decrease more rapidly at lower pH for the prolactin receptor. 
Thus the yield of prolactin receptor at pH 6.0, 7.0, and 8.0 was 
6.0, 9.1, and 8.5%, respectively, whereas the yields of GH 
receptor were 9.1, 9.8, and 9.2%, respectively. These figures 
are consistent with the wide pH optimum reported for the GH 
receptor (47). It should be noted that hGH was coupled to the 
gel at pH 8.5 because preliminary experiments indicated that 
this gave a better yield of receptor than pH 5.9 coupling. 
A comparison of yields with bGH and hGH affinity gels was 
also undertaken, and it was found that yields were consider- 
ably lower with bGH gels coupled with the same hormone 
concentration as hGH gels. Thus with gels coupled at 15 mg 
of hormone/g of gel, hGH gels gave 8.4% yield, whereas bGH 
gels gave only a 2.5% yield. Kelly et al. (2) found that ‘251- 
bGH did not bind as effectively as ‘251-hGH to liver mem- 
branes, and this may be in part a reflection of the same 
phenomenon. Because bulk bGH is more available than bulk 
hGH, we attempted to modify the bGH affinity by coupling 
the monomer, which may be the biologically active form. 
IiOURS OF INCUBATION 
FIG. 7. Time course of growth and lactogenic receptor binding in 
soluble rabbit liver extracts. Rabbit liver membrane protein (110 pg) 
was added to eight sets of duplicate tubes labeled 0, 30 min, 1, 3, 6, 
24 h. Two sets received 46,000 cpm of ‘?hGH with 1 pg/ml of bGH 
(nonspecific binding tubes), and two sets received 46,000 cpm of “‘I- 
hGH alone. One of each pair was incubated (shaking) for the stated 
times at 22’C, and one at 4°C. At the end of this time the reaction 
was stopped with cold buffer and processed as usual. Two other sets 
received “‘I-hGH and oPr1 (1 ag/ml), while the last two sets received 
‘*‘I-hGH alone. These were treated in a similar fashion to the first 
four sets. The figure shows percentage of specific binding (% S.B.) 
using bGH at 22°C (A) or 4°C (O), and specific binding using oPr1 at 
22°C (A) or 4°C (0). 
Sonenberg et al. (48) have shown that bGH exists predomi- 
nantly as the monomer above pH 9.0, so bGH was coupled at 
pH 9.0 after a pH 10.5 preincubation. No significant difference 
in yield between monomer and dimer couplings was observed 
(yield of 2.5% versus 2.0%, respectively). 
Finally, it should be mentioned that the relatively low 
affinity of the GH receptor for hGH gels (compared to the 
prolactin receptor) makes it necessary to wash the gels with 
cold Tris/Triton buffer after the batch incubation period. 
Further Large Scale Purification of the GH Receptor 
An examination of the urea fraction by SDS slab gel elec- 
trophoresis showed at least 15 bands spaced throughout the 
gel (not shown) so that further purification was desirable. 
Analytical isoelectric focusing of the urea fraction (gel not 
shown, method described under “Materials and Methods”) 
revealed a considerable number of protein bands located away 
from the region containing the GH-binding activity (pH 4.4 to 
5.4) (see also Fig. 12), so that preparative isoelectric focusing 
was examined as a means of further purification. 
Accordingly, bulk quantities (250 to 500 g) of pregnant 
rabbit liver were processed through to the end of the affinity 
purification stage. Membranes were extracted twice with Tri- 
ton X-305 before Triton X-100 treatment, since that detergent 
solubilizes a much lower proportion of membrane proteins 
than Triton X-100 because it has a higher hydrophobic-lipo- 
philic balance (49). Triton X-305 extraction was followed by 
double Triton X-100 extraction to remove the remainder of 
the solubilizable receptors. Each detergent extract was then 
processed separately. Both extracts were hGH affinity-chro- 
matographed by recycling the eluate from the initial chro- 
matography through the same column up to three more times, 
although one recycle was generally found to be sufficient for 
optimal yields. Despite the protease inhibitors, the nonspecific 
binding in the extracts became very high after one or two 
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FIG. 8. Preparative isoelectric focusing of affinity-purified GH re- 
ceptor. Concentrates (20 to 40 ml) of urea affinity fractions were 
applied to an LKB 110-ml preparative IEF column as described under 
“Materials and Methods” and focused for 48 h at 4°C. Columns were 
eluted in 3.0-ml fractions and after adjusting the pH to 7.5 with 2 M 
NaOH or HCl, 50 ~1 of these fractions were assayed for ‘*?-bGH 
specific binding (S.B.) in the soluble receptor assay. Triton X-100 or 
X-305 absorb strongly at 280 nm, so the 280 nm absorbance pattern 
is not shown. The continuous line represents the pH gradient directly 
after elution, and the dotted line the specific binding (%SE). Recov- 
eries averaged 80%. 
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Purification of a Nonprimate Growth Hormone Receptor 6821 
cycles, apparently because of the release of bound hGH by 
protease action, since these extracts depressed binding of 1251- 
hGH in the soluble radioreceptor assay. 
After dialysis and concentration of the urea fractions on 
Amicon UM2 ultrafiltration membranes, they were submitted 
to preparative IEF by the procedure outlined under “Materi- 
als and Methods.” Most of the binding activity localized in 
the range pH 4.0 to 5.0 (Fig. 8), and the indicated fractions 
were pooled and reconcentrated on UM2 membranes to about 
20 ml, The concentrate was dialyzed twice for 12 h at 4°C 
against 1 M NaCl/Tris/Triton to remove the majority of the 
% S.B., , , , , , , , , , , 
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FIG. 9. Elution pattern of GH receptor on Sepharose 6B after 
preparative IEF. After concentration to 20 ml by ultrafiltration and 
dialysis against 1 M NaCl/Tris/Triton, samples were loaded onto a 
Sepharose 6B column (118 x 2.55 cm) equilibrated with Tris/Triton 
at 4°C. The column was run at 17 ml/h and a head of 60 cm. Samples 
(8.0 ml) were collected, and 20-~1 lots assayed for ?-bGH specific 
binding. Protein was assayed by the modified Lowry method. Peak 
activity fractions were pooled and concentrated by ultrafiitration. 
Recoveries were usually about 75%. The column was calibrated with 
ovalbumin, serum albumin, y-globulins, catalase, apoferritin, blue 
dextran and Na[‘251]. Marker proteins were detected by absorbance 
280 nm and Lowry determinations. p, protein; -- -, % specific 
binding (%S.B.). Vo, void volume; VT, bed volume of column. 
TABLE I 
Liver growth hormone receptor purification; purification factors 
and recoveries 
AII data are based on Scatchard analysis of individual fractions 
with ‘?-oGH. Protein estimations are described under “Materials 
and Methods.” 
Growth hormone receptor purification 
Fraction Specific activity Purification Recovery factor 
Whole homogenate 
15,000 X g supernatant 
100,000 X g pellet 
Triton X-305, superna- 
tant 
Triton X-100 superna- 
tant 
Urea affinity (Triton X- 
305) 
Urea affinity (Triton X- 
w 
IEF (T&on X-305) 
IEF (T&on X-100) 
Sepharose 6B (Triton X- 
305) 
Sepharose 6B (Triton X- 
100) 
fmW& 
95.4 
119 
366 
688 
349 
45,700 
28,000 294 5.2 
>1OO,ooO >1048 2.9 
>35,000 >367 1.3 
>767.000 >8000 1.74 
>114,000 11195 0.24 
-fold o/c 
I 100 
1.2 71 
3.8 60 
7.2 59 
3.7 18.5 
480 3.7 
n Determined with ““I-oGH tracer. 
ampholytes, and then run on a Sepharose 6B column, as 
outlined under “Materials and Methods.” Gel filtration at this 
stage proved to be particularly effective, and most of the 
(modified) Lowry reactive material was separated from the 
binding activity (Fig. 9). Ampholyte interference in the protein 
assay was avoided by multiple trichloroacetic acid-deoxycho- 
late precipitation steps in the presence of 1 M NaCl before 
assay (39). The significance of the binding to the low molecular 
weight fractions (~40,000) is uncertain. 
Table I gives the purification factors and yields obtained by 
this procedure, which has many similarities to the method of 
Jacobs et al. (50) for purification of the insulin receptor, 
published after completion of this work. While the final yield 
is quite low (owing largely to losses during affinity chroma- 
tography and UM2 concentration), the degree of purification 
is considerable, especially in the case of the Triton X-305 
extracted receptor. It is likely that the lower degree of purifi- 
cation obtained with Triton X-100 extraction after Triton X- 
305 extraction of the membranes could be improved if Triton 
X-100 extraction alone were used. The actual purification 
obtained by affinity chromatography is only about 70-fold; 
this low figure is probably the result of the mild wash condi- 
tions necessary to avoid washing the GH receptor off the 
column. Isoelectric focusing gave only up to 2-fold purification, 
but the Sepharose column gave nearly &fold in the case of 
the Triton X-305-extracted receptor. Values for purification 
factors are minimum values, the uncertainty being a result of 
uncertainty in some of the protein estimates. We have been 
unable to obtain the 70% yields of hGH receptor by affinity 
TABLE II 
Liver prolactin receptor purification; purification factors and 
recoveries 
AII data are based on Scatchard analysis of individual fractions 
with ?-oPr1 protein estimates as described under “Materials and 
Methods.” lOOk-g pellet is 100,000 X g pellet. 
Summarv of ourification of liver orolactin receotor 
Fraction Specific activity” Purification Recovery 
fmolhg -fold % 
Whole homogenate 66 1 100 
lOOk-g pellet 234 3.5 60 
Triton X-100 supernatant 645 9.8 50 
MgCls affinity fraction 
n Y-0Prl. 
4000-5000 61-76 14 
POST 
SEPHAROSE 
1 
n / 
FIG. 10. SDS slab gel electrophoresis of purified GH receptor; 
method of LaemmIi (41) as described under “Materials and Methods.” 
Standards on right (from bottom) cytochrome c, cr-chymotrypsinogen, 
ovalbumin, serum albumin, galactosidase. The post-Sepharose recep- 
tor was concentrated loo-fold and a 20-/d sample run on the SDS gel 
after mercaptoethanol reduction. The crude Triton X-305 (TX 305) 
and Triton X-100 (TX 100) supernatants (Slv) are included for com- 
parison (approximately 50 pg each). 
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6822 Purification of a Nonprimate Growth Hormone Receptor 
chromatography reported by McIntosh et al. (25), despite 
optimization of all conditions. 
Table II shows that purification of the prolactin receptor 
from liver was not great (approximately 70-fold), and since 
the rabbit mammary can be used to purify a rabbit prolactin- 
specific receptor which is at least 10 times more active per mg 
of protein (44), further purification was not attempted. 
OVALBUMIN 
GAMMA GLOBULIN 
011 1000 
MOLECULAR WEIGHT x 1O-3 
FIG. 11. Estimation of approximate mclecular weight of GH recep- 
tor (GHR) by Sepharose 6B gel filtration. Conditions of gel filtration 
are described in Fig. 8. Samples (20 ml) were applied in Tris/Triton 
buffer. KAv, liquid/gel phase partition coefficient. 
SLICE NUMBER (O.Scm.) 
FIG. 12. Analytical isoelectric focusing of T&on X-lOO-solubilized 
rabbit liver GH receptor. Slab gel IEF on an LKB Multiphore unit in 
the presence of 0.1% Triton X-100 as described under “Materials and 
Methods.” Samples containing 750 H of protein were applied in 75- 
d volume to Whatman No. 1MM wicks placed on the cathodal side 
of the gel. Appropriate markers (cytochrome c, ferritin) were run to 
examine uniformity of the pH gradient. Samples (230 ~1) were incu- 
bated with either 30 d of 1 M acetate/acetic acid, pH 5.5, alone or 30 
d of this buffer plus 10 l.lg of neuraminidase for 30 min at 37”C, final 
pH 5.85. After the incubation, samples were centrifuged to remove 
any turbidity and 75-d aliquots applied to the wicks. IEF was for 4 h 
at 4°C and 8 watts, and after disassembly, the gel was cut into 0.5-cm 
segments which were eluted with Tris/Triton and assayed for specific 
‘%I-oGH binding as described in under “Materials and Methods.” 
Neuraminidase digestion (0) did not change the percentage of specilic 
binding (%5’B) ability of the receptor significantly compared to the 
control (0) (recovery of control 10096, neuraminidase 87%). 
SDS Gel Electrophoresis 
When the highly purified Triton X-305-extracted GH recep- 
tor was concentrated loo-fold on UM2 membranes and sub- 
jected to SDS slab gel electrophoresis, the staining pattern 
seen in Fig. 10 was obtained. Three bands were visible, with 
a major band at 75,000 to 80,000 daltons. The diffuse pattern 
at the front is caused by the Triton X-100 in these concen- 
trated samples, the detergent having formed a mixed micelle 
with the SDS. Technical problems caused by the simultaneous 
removal of Triton X-100 and protein during attempts to free 
the protein of Triton X-100 precluded the presentation of 
better gels. It should be noted that the mammary Prl receptor 
shows only two bands on SDS gels after affinity chromatog- 
raphy, and both bands were very close to the position of the 
main GH receptor band i.e. 75,000 to 80,000 daltons (gel not 
shown), 
Properties of the GH Receptor 
Molecular Weight by Gel Filtration-An approximate es- 
timate of the molecular weight of the purified receptor was 
obtained by calibrating the preparative Sepharose 6B column 
with standards. Fig. 11 shows that, assuming the receptor is 
not markedly asymmetrical or of unusual partial specific 
volume (assumptions which are probably not valid (51)), the 
molecular weight of the purified receptor is around 300,000. A 
Stokes radius of 62 A can also be derived from the data (52). 
These values are close to those reported for the insulin recep- 
tor by Cuatrecasas (51). The significance of the smaller re- 
10.01 
I 
INITIAL CONCENTRATION OF STANDARD (n~/ml.] 
INITIAL CONCENTRATION OF STANDARD (rig/ml.) 
FIG. 13. Displacement curves; lz51-oGH and ‘251-oPrl binding to 
highly (>8000-fold) purified GH receptor; A, ‘*?-oGH binding; B, T- 
oPr1 binding. Standard PEG assay as described under “Materials and 
Methods,” using ~0.05 pg of protein for lz51-oGH and <0.20 H of 
protein for ‘251-oPrl binding. Ka for lBI-oGH with oGH 1.2 x lo9 M-‘, 
with oPr10.7 X 10’ M-‘. A-A, NIH bGH lCO3A; H, NIH oPr1 
s-12. 
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Purification of a Nonprimate Growth Hormone Receptor 6823 
tarded peak of specific binding (about 25% of the eluted 
specific binding, <40,000 daltons) is uncertain, but other work- 
ers have identified receptor subunits or fragments capable of 
binding to their hormone (53-55). 
Isoelectric Focusing of GH and Prl Receptors; Evidence 
for a Sialoglycoprotein Receptor-Analytical isoelectric fo- 
cusing of purified liver GH and prolactin receptors (as de- 
scribed under “Materials and Methods”) reveals a difference 
of approximately 0.5 pH unit in their isoelectric points (ap- 
proximately 4.6 for the GH receptor and approximately 5.1 
for the prolactin receptor). However, there is considerable 
charge heterogeneity, and this appears to be the result of a 
heterogeneous content of siahc acids, since neuraminidase 
treatment of the GH receptor raises its p1 to approximately 
6.2 and lessens the charge heterogeneity somewhat (Fig. 12). 
Thus the GH receptor resembles the insulin receptor again in 
that both are sialoglycoproteins (56). 
Specificity Studies-Displacement analysis of the highly 
(>8000-fold) purified receptor (Fig. 13) provides strong sup- 
port for the conclusions derived from Scatchard analysis of 
binding to crude membrane fractions. Thus the purified re- 
ceptor binds both lz51-oGH and 1251-oPrl, and both hormones 
are capable of displacing lz51-oGH and oPr1 with affinities 
similar to those calculated from the membrane system. It can 
be seen that bGH can now displace ‘251-oPrl to the same 
extent as oPr1 (in contrast to the crude membrane studies) 
and with the same affinity. In other words, the specific pro- 
lactin binding portion of ‘251-oPrl binding seen in crude mem- 
branes has been removed, and the GH receptor that remains 
exhibits equal affinity for oPr1 or bGH. 
DISCUSSION 
The separation of growth hormone and prolactin receptors 
described in this paper makes use of a phenomenon which is 
at present poorly understood, the effect of the polarity of the 
receptor environment on its ability to bind the hormone. In 
this case, solubilization of the liver (and mammary) prolactin 
receptors with Triton leads to a 4-fold increase in affinity for 
prolactin, while solubilization of the GH receptor has a slight 
effect on its affinity for GH. As a consequence, GH receptors 
can be displaced from hGH affinity columns with moderate 
concentrations of urea, while displacement of the prolactin 
receptors requires the more vigorous action of 5 M MgC12. An 
effect of solubilization with nonionic detergents on receptor 
affinity is not novel; the muscarinic cholinergic receptor will 
not bind specific ligands in the presence of detergents (57), 
and the binding ability of epidermal growth factor receptor is 
also lost on solubilization.2 An important role for membrane 
phospholipids has also been suggested for ACTH, glucagon, 
TRF, LH-hCG, adrenergic and cholinergic receptors, all of 
which exhibit decreased binding to ligand after phospholipase 
treatment (5). Insulin and lactogenic hormone binding to rat 
liver appears to be enhanced by phospholipase treatment (58, 
59), and lipids appear to be important in determining the 
conformation of the gonadotropin receptor-binding site (60). 
The inability of other workers to separate growth and 
lactogenic receptors is in large part attributable to the fact 
that most workers have tended to use ‘251-hGH as a tracer for 
studies with rabbit liver GH receptors (1, 4, 24, 25), making 
the tacit assumption that lactogenic receptors (which will also 
bind ‘251-hGH, see Refs. 29 and 45) were insignificant in 
number. This was despite the publication by Parke and For- 
sythe (27) of a radioreceptor assay method for prolactin using 
lyophilized rabbit liver membranes. No surprisingly, therefore, 
Kelly et al. (2) found that specific binding of lz51-hGH was 
* M. D. Hollenberg, personal communication. 
greater than ‘251-bGH binding. These workers were, neverthe- 
less, able to show displacement of ‘251-bGH by oPr1 and lz51- 
oPr1 by bGH identical with that reported here, although these 
workers chose to pass over the observation. Herington and 
Veith (24) noted that bGH and oGH were able to displace 1251- 
hGH only partially and show significant displacement of 1251- 
hGH by oPr1 on their displacement curve for soluble extracts. 
These workers postulated a specific hGH binding site in rabbit 
liver to account for their data, which would seem rather 
strange in the rabbit. While the 20 to 30% high affinity 
prolactin receptor content of rabbit liver (relative to its GH 
receptor content) may not be critical in the hGH radioreceptor 
assay, it does become important when attempting purification 
of the GH receptor, especially since solubilization increases 
the affinity of the prolactin receptor for hGH affinity gels. 
We were fortunate to possess specific anti-rabbit prolactin 
receptor antiserum which was found to inhibit binding of 12?- 
oPr1 to its specific receptor in the liver, but not ‘251-bGH 
binding, thus demonstrating the separate identity of these two 
receptors. Scatchard analysis of the four combinations of oPr1 
and bGH tracers and unlabeled hormones led us to postulate 
the existence of two prolactin-binding sites in the rabbit liver 
but only one GH-binding site. The fact that bGH displacement 
of 1251-oPrl was only partial further supported the concept of 
a separate prolactin receptor not liable to competition by 
bGH. The ‘251-bGH binding, on the other hand, could be 
totally displaced by oPr1, although the affinity for oPrl was 
lo-fold lower in this system. Conversely, bGH displaced 1251- 
oPr1 with high affinity, which we attributed to the fact that 
‘251-oPrl had bound to the GH receptor and was as efficiently 
displaced by bGH as if lz51-bGH trace had been used. There 
are problems with Scatchard analysis in such heterogeneous 
systems, and we are still concerned with the lack of correlation 
of binding capacities in this system and the variation in the 
ratio of capacities of GH receptor measured by oPr1 and bGH 
displacement in different preparations. These differences may 
be the result of the fact that oPr1 binding to the prolactin 
receptor is not taken into consideration in the analysis of 
displacement of ‘251-bGH by oPr1, or they may result from 
differences in the specific activities of different lots of tracers. 
The alternative hypothesis, that there are two GH receptors, 
one GH specific and the other shared with prolactin, would 
seem unlikely because displacement of ‘251-bGH by oPr1 is 
total. 
The power of affinity chromatography as a tool is illustrated 
by its application to this problem. Using differential affinity 
chromatography, we have been able to separate the two 
receptors present in solubilized liver extracts, a high affinity 
prolactin-specific receptor very similar in its binding charac- 
teristics (affinity and inability to be displaced by bGH) to the 
well characterized mammary receptor (33) and a receptor with 
relatively high affinity for GH but low affinity for prolactin. 
Further binding analysis with the highly purified GH receptor 
supported this notion of a receptor with dual specificity and 
gave affinity values close to those derived from studies with 
crude membranes. In work to be presented elsewhere, anti- 
bodies raised against the purified GH receptor were tested for 
inhibition of binding of ‘251-bGH to this receptor, and the 
specific binding of both ‘251-bGH and ‘251-oPrl was totally 
inhibited by the antiserum, and, insofar as was examined, with 
apparently equal effectiveness. This antiserum failed to inhibit 
the binding of ‘251-oPrl to its specific MgClz-eluted receptor, 
whereas the specific anti-(mammary) prolactin receptor anti- 
serum did so, although this latter antiserum was ineffective 
against the urea (GH receptor) fraction. 
A consideration of the sequence homologies between oPr1 
and bGH (about 28% (42)) might have led us to countenance 
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6824 Purification of a Nonprimate Growth Hormone Receptor 
some overlap of specificity in the rabbit GH receptor, espe- 
cially when the overlap seen with hGH is considered. Bovine 
and ovine prolactins are almost identical in sequence, so that 
the ability of bPr1 to displace ‘““I-oGH is expected. Rat pro- 
lactin is quite different from the other prolactins (42), and this 
may account for its inability to displace ‘?-oGH from the GH 
receptor. Displacement of ““I-bGH by oPr1 and its converse 
has been reported in the rat liver by Ranke et al. (ll), but the 
heterologous hormone is far less effective in this species, and 
part of the effect may be the result of cross-contamination. It 
should be pointed out that a number of other receptors exhibit 
site sharing with a variety of ligands. Thus somatomedins, 
VSA, and NSILA-s compete for the insulin receptor (19), 
vasopressin and oxytocin have overlapping receptor specificity 
(61, 62), and both LH and hCG can displace TSH from its 
receptor (54). 
The physiological significance of the overlap of specificity 
in the rabbit and possibly rat liver is uncertain, but it is known 
that ovine prolactin is weakly growth promoting in the intact 
rat (63) and that it is as effective as GH in generating soma- 
tomedin in perfused rat livers (64), although it would seem 
likely that the latter phenomenon is mediated through the 
lactogenic receptors. Ovine and bovine growth hormones are 
not lactogenic in the rabbit (65) in accord with their inability 
to displace oPr1 from the specific prolactin receptor of the 
mammary gland.3 We are, in a strict sense, unable to claim 
that we have isolated a GH receptor until we have shown its 
antiserum can block the biological effects of GH in a similar 
manner to the demonstration by Shiu et al. (35) with anti- 
prolactin receptor antibodies. Until that demonstration, we 
should more correctly refer to the binding protein as an 
acceptor, not a receptor. However, the range of concentrations 
of GH found in the rabbit (66) correlate well with the displace- 
ment curves and affinity for GH receptor here. 
There appear to be many similarities between insulin recep- 
tors and GH receptors. Both appear to be glycoproteins of 
similar size (62 A Stokes radius for the GH receptor, 70 A for 
the insulin receptor) and isoelectric point (36, 50, 51), and 
both seem to be tetrameric with 75,000- to 80,000-dalton 
subunits (53), although this is highly speculative for the GH 
receptor in the absence of activity data. It should be men- 
tioned that we have good evidence (binding to concanavalin 
A and neuraminidase digestion followed by IEF) that the 
rabbit mammary prolactin receptor is a glycoprotein, and an 
examination of the published information on this receptor 
(44) shows the hormone *receptor complex has a liquid/gel 
phase partition coefficient (&v) of 0.40, similar to the value 
of 0.42 obtained for the GH receptor. The molecular weight 
value of GH receptor must remain provisional in the absence 
of further physicochemical studies (sucrose density gradients) 
because of the likely asymmetry and glycoprotein nature of 
these receptors. 
A final comment is needed on the purity of the receptor 
obtained after affinity chromatography, IEF, and gel filtration. 
Since this product binds approximately 750 pmol of “‘I-bGH/ 
mg of protein, then assuming that 1 mol of hormone binds per 
BO,OOO-dalton subunit, the final purity based on activity is 
better than 6%. It is highly likely that this is an underestimate, 
since the receptor tends to lose activity on storage, and the 
binding estimates have not been corrected for bindable hor- 
mone (less than 50% for lz51-bGH). Nevertheless, it is apparent 
that this receptor has not yet been fully purified. 
I’ This phenomenon of site overlap is not seen in the homologous 
species, since oPrl will not displace ‘?-oGH from sheep liver mem- 
branes (data not shown). 
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Additions and Corrections 
Vol. 254 (1979) 6815-6825 
Purification and partial characterization of a nonpri- 
mate growth hormone receptor. 
Michael J. Waters and Henry G. Friesen 
Page 6816, Right-hand column, Line 5 in the second 
paragraph under “Conditions of Affinity Chromatog- 
raphy” 
The authors wish to insert the word “slowly” and change “5 
volumes” to “10 volumes” in the sentence shown below, and 
to add the following statement: 
The column was subsequently washed slowly with 10 volumes of 6 
M urea in Tris/Triton, followed by Tris/Triton, and then eluted slowly 
with 3 volumes of 5 M MgCl, in Tris/Triton (at 30°C) into ice. A 
thorough wash of the column with 6 M urea is necessary to totally 
remove residual growth hormone receptors. 
The entire corrected paragraph is reproduced here: 
After incubation, the gel was poured into a column (1.7 x 15 cm) 
with sintered glass support and washed under gentle suction with at 
least 150 volumes of ice-cold Tris/Triton buffer. The gel was then 
eluted slowly with 3 volumes of 4 M urea in Tris/Triton and the urea 
eluate collected in ice. The column was subsequently washed slowly 
with 10 volumes of 6 M urea in Tris/Triton, followed by Tris/Triton, 
and then eluted slowly with 3 volumes of 5 M MgC12 in Tris/Triton 
(at 30°C) into ice. A thorough wash of the column with 6 M urea is 
necessary to totally remove residual growth hormone receptors. After 
another extensive wash with Tris/Triton, the gel was ready for 
recycling of the extract. Urea and MgC12 eluates were dialyzed twice 
against 50 volumes of Tris/Triton at 4”C, and assayed for binding 
prior to concentration on Amicon UM2 ultrafiltration membranes or 
by dialysis against Ficoll. Great care must be taken with ultrafiltration 
to avoid loss of receptors onto the UM membranes when volumes 
become small. 
We suggest that subscribers photocopy these corrections and insert the photocopies at the 
appropriate places where the article to bc corrected originally appeared. Authors are urged to 
introduce these corrections into any reprints they distribute. Secondary (abstract) services 
are urged to carry notice of these corrections as prominently as they carried the original abstracts. 
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